A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution

scientific article

A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NUCMEDBIO.2009.01.001
P698PubMed publication ID19423007

P50authorFares Al-EjehQ41536653
Michael P. BrownQ42068411
Benjamin ThierryQ44481875
Jocelyn M DarbyQ55363002
P433issue4
P921main subjectantibodyQ79460
P304page(s)395-402
P577publication date2009-03-26
P1433published inNuclear Medicine and BiologyQ7067979
P1476titleA simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution
P478volume36

Reverse relations

cites work (P2860)
Q55042518212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
Q50138482212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
Q33413085APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy
Q38014923Antibody-drug conjugates - a perfect synergy
Q35061657Autoradiography imaging in targeted alpha therapy with Timepix detector
Q28474893Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors
Q39634203Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging
Q34996427Comparison of the in vivo distribution of four different annexin a5 adducts in rhesus monkeys
Q41832797Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody
Q35666005EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
Q37438751The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.
Q37268891[(64) Cu]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice

Search more.